Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Juva Life Inc JUVAF

Juva Life Inc. is a life science company with both pharmaceutical research and development and consumer-facing operations in cannabis production and distribution. It is vertically integrated and consists of five divisions: Juva Cultivation, Juva Research, Juva Manufacturing, Juva Distribution, and Juva Retail. Juva Cultivation focuses on cultivating and distributing cannabis to medical and recreational cannabis users. Juva Retail is a network of retail cannabis facilities that serves the San Francisco Bay Area and other areas. Juva Research researches and develops cannabis products to deliver the right medicine to the right patient at the right time. Juva Manufacturing create both Juva branded as well as white-label products for other recreational and medical related cannabis companies. Juva Distribution distributes Juva cultivated bulk cannabis, Juva branded products and may distribute products from other licensed cannabis companies.


GREY:JUVAF - Post by User

Post by SpaceLabson Jan 10, 2022 12:30am
280 Views
Post# 34298823

CEO Doug is a LIAR, wants his WARRANTS Exercised,in Feb 2022

CEO Doug is a LIAR, wants his WARRANTS Exercised,in Feb 2022His trial is dated to 2027 when he will ROOST with JUVA Insiders, share price TANKS DAILY.

The Company’s business focus is the development of safe and effective treatments targeting the global anti-inflammatory therapeutics market is estimated to reach USD $191.4 billion by 2027, as reported by Fortune Business Insights.

ALONG WAIT, not buying this DIRT.

 
<< Previous
Bullboard Posts
Next >>